γ-Interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma

Cell Growth and Differentiation

Volumn 7, Issue 3, 1996, Pages 289-300

  Harvat, Beth L ^a   Jetten, A M ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; RETINOBLASTOMA PROTEIN;

ARTICLE; BREAST EPITHELIUM; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION;

BREAST; BREAST NEOPLASMS; CARCINOMA; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE; DNA; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; EPITHELIUM; G1 PHASE; HUMANS; INTERFERON TYPE II; PHOSPHOPROTEINS; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P130; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0029832323     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Delvenne, P., al-Salah, W., Gilles, C., Thiry, A., and Boniver, J. Inhibition of growth of normal and human papiliomavirus-transformed keratinocytes in monolayer and organotypic cultures by interferon-γ and tumor necrosis factor-α. Am. J. Pathol., 146: 589-598, 1995.
2. Mallat, A., Preaux, A. M., Blazejewski, S., Rosenbaum, J., Dhumeaux, D., and Mavier, P. Interferon-α and γ inhibit proliferation and collagen synthesis of human Ito cells in culture Hepatology, 21: 1003-1010, 1995
3. Mauerhoff, T., Belflore, A , Pujol-Borrell, R , and Bottazzo, G. F. Growth inhibition of human endothelial cells by human recombinant tumor necrosis factor α and interferon-γ. Tumori, 80: 301-305, 1994
4. - human hematopoietic progenitor cells. J. Exp. Med., 180. 1177-1182, 1994.
5. Palumbo, A., Battaglio, S., Napoli, P., Omedé, P., Fusaro, A., Bruno, B., Boccadoro, M., and Pileri, A. Recombinant interferon-γ inhibits the in vitro proliferation of human myeloma cells. Br. J. Haematol., 86: 726-732, 1994.
6. Jetten, A. M., Nervi, C., and Vollberg, T. M. Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoids. Monogr. Natl. Cancer Inst., 13: 93-100, 1992.
7. Jia, S. F., and Kleinerman, E. S. Antitumor activity of TNF-α, IL-1, and IFN-γ against three human osteosarcoma cell lines. Lymphokine Cytokine Res., 10: 281-284, 1991.
8. Lienard, D., Eggermont, A. M., Schraffordt-Koops, H., Kroon, B. B., Rosenkaimer, F., Autier, P., and Lejeune, F. J Isolated perfusion of the limb with high-dose tumour necrosis factor-α (TNF-α), interferon-γ (IFN-γ) and melphalan for melanoma stage III: results of a multi-centre pilot study. Melanoma Res., 4 (Suppl. 1): 21-26, 1994.
9. Ono, M., Tanaka, N., and Orita, K. Positive interactions between human Interferon and cepharanthin against human cancer cells in vitro and in vivo. Cancer Chemother. Pharmacol, 35: 10-16, 1994.
10. van Dijk, J., Uemure, H., Beniers, A. J., Peelen, W. P., Zegveld, S. T., Fleuren, G. J., Warnaar, S. O., and Oosterwijk, E. Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts. Int. J Cancer, 56: 262-268, 1994.
11. Markman, M., Reichman, B., Hakes, T., Curtin, J., Jones, W., Lewis, J. L., Jr., Barakat, R., Rubin, S., Mychalczak, B., Saigo, P., Almadrones, L., and Hoskins, W. Intraperitoneal chemotherapy in the management of ovarian cancer. Cancer (Phila.), 71 (Suppl. 4): 1565-1570, 1993.
12. Lejeune, F., Bauer, J., Leyvraz, S., and Lienard, D. Disseminated melanoma, preclinical therapeutic studies, clinical trials, and patient treatment. Curr. Opin. Oncol., 5: 390-396, 1993.
13. Chen, J. T., Hasumi, K., and Masubuchi, K Interferon-α, interferon-γ and sizofiran in the adjuvant therapy in ovarian cancer: a preliminary trial. Biotherapy, 5: 275-280, 1992.
14. Wandl, U. B., Kloke, O., Nagel-Hiemke, M., Moritz, T., Becher, R., Opalka, B., Holtkamp, W., Bartels, H , Seeber, S., and Niederle, N. Combination therapy with interferon α-2b plus low-dose interferon-γ in pretreated patients with Ph-positive chronic myelogenous leukaemia. Br. J. Haematol., 81: 516-519, 1992.
15. Baron, S., Tyring, S. K., Fleischmann, W. R., Jr., Coppenhaver, D. H., Niesel, D. W., Klimpel, G. R., Stanton, G J., and Hughes, T. K. The interferons: mechanisms of action and clinical applications. J. Am. Med. Assoc., 266: 1375-1383, 1991.
16. Darnell, J. E., Jr., Kerr, I. M., and Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Washington DC), 264: 1415-1421, 1994.
17. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
18. Whyte, P. The retinoblastoma protein and its relatives. Semin. Cancer Biol., 6: 83-90, 1995.
19. Dyson, N. pRB, p107 and the regulation of the E2F transcription factor. J. Cell Sci. Suppl., 18: 81-87, 1994.
20. Wang, J. Y. J., Knudsen, E. S., and Welch, P. J. The retinoblastoma tumor suppressor protein Adv. Cancer Res., 64: 25-85, 1994.
21. Adams, P. D., and Kaelin, W. G., Jr. Transcriptional control by E2F. Semin. Cancer Biol., 6: 99-108, 1995.
22. Müller, R. Transcriptional regulation during the mammalian cell cycle. Trends Genet., 11: 173-178, 1995.
23. La Thangue, N. B DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control. Curr. Opin. Cell Biol., 6: 443-450, 1994.
24. Hsiao, K-M., McMahon, S. L., and Famham, P. J. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes & Dev., 8: 1526-1537, 1994.
25. Johnson, D. G., Ohtani, K., and Nevins, J. R. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes & Dev., 8: 1514-1525, 1994.
26. Oswald, F., Lovec, H., Möröy, T., and Lipp, M. E2F-depandent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oncogene, 9: 2029-2036, 1994.
27. cdc2 expression and normal p53 suppresses cyclin A expression. Exp. Cell Res., 270: 94-101, 1994.
28. Lam, E. W. F., and Watson, R. J. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J., 12: 2705-2713, 1993.
29. Henglein, B., Chenivesse, X., Wang, J., Eick, D., and Bréchot, C. Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc. Natl. Acad. Sci. USA, 91: 5490-5494, 1994
30. Shan, B., Chang, C-Y., Jones, D., and Lee, W-H. The transcription factor E2F-1 mediates the autoregulation of RB gene expression. Mol. Cell. Biol., 14: 299-309, 1994.
31. Hijrnans, E. M., Voorhoeve, P. M., Beijersbergen, R. L., van 't Veer, L. J., and Bernards, R. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol., 15: 3082-3089, 1995.
32. Vairo, G., Livingston, D. M., and Ginsberg, D. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes & Dev., 9. 869-881, 1995.
33. Saunders, N. A., and Jetten, A. M. Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon-γ J. Biol Chem , 269: 2016-2022, 1994.
34. Saunders, N. A., Smith, R. J., and Jetten, A. M Differential responsiveness of human bronchial epithelial cells, lung carcinoma cells, and bronchial fibroblasts to interferon-γ in vitro. Am. J. Respir. Cell Mol. Biol , 11: 147-152, 1994.
35. Halevy, O., Novitch, B. G., Spicer, D. B , Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington DC), 267: 1018-1021, 1993.
36. 1 arrest. Cell, 76: 1013-1023, 1994.
37. Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., and Smith, J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211: 90-98, 1994.
38. Schwarz, J. K., Bassing, C. H., Kovesdi, I., Datto, M. B., Blazing, M., George, S., Wang, X-F., and Nevins, J. R. Expression of the E2F1 transcription factor overcomes type β transforming growth factor-mediated growth suppression Proc. Natl. Acad. Sci. USA, 92: 483-487, 1995.
39. Qin, X-Q., Livingston, D. M., Ewen, M., Sellers, W. R., Arany, Z., and Kaelin, W. G., Jr. The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol., 15: 742-755, 1995.
40. Johnson, D. G., Schwarz, J. K., Cress, W. D., and Nevins, J. R Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature (Lond.), 365: 349-352, 1993.
41. Shan, B., and Lee, W-H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol., 14: 8166-8173, 1994.
42. 1/S boundary-specific enhancer of the rat cdc2 promoter. Mol. Cell. Biol., 15: 2882-2892, 1995.
43. Slansky, J. E., Li, Y., Kaelin, W. G., and Farnham, P. J. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol. Cell Biol., 13: 1610-1618, 1993.
44. 1/S-regulatory genes. Mol. Cell Biol., 15: 4215-4224, 1995.
45. Neuman, E., Flemington, E. K., Sellers, W. R., and Kaelin, W. G., Jr. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol. Cell. Biol., 14: 6607-6615, 1994.
46. Melarned, D., Tiefenbrun, N., Yarden, A., and Kimchi, A. Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells. Mol. Cell. Biol., 13: 5255-5265, 1993.
47. Rustgi, A K , Dyson, N., and Bernards, R. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature (Lond.), 352: 541-544, 1991.
48. Bremner, R., Cohen, B. L., Sopta, M., Hamel, P. A., Ingles, C. J., Gallie, B. L., and Phillips, R. A. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell. Biol., 15: 3256-3265, 1995.
49. Emili, A., and Ingles, C. J. Promoter-dependent photocross-linkmg of the acidic transcriptional activator E2F-1 to the TATA-binding protein. J. Biol. Chem., 270: 13674-13680, 1995.
50. Hateboer, G.,Timmers, H.T. M , Rustgi, A. K , Billaud, M., van 't Veer, L. J., and Bernards, R. TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. Proc. Natl. Acad. Sci. USA, 90: 8489-8493, 1993.
51. Bennett, M. R., Littlewood, T. D., Hancock, D. C., Evan, G I., and Newby, A. C. Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest? Biochem. J., 302: 701-708, 1994.
52. Vairo, G., Royston, A K., and Hamilton, J. A Biochemical events accompanying macrophage activation and the inhibition of colony-stimulating factor-1-induced macrophage proliferation by tumor necrosis factor-α, interferon-γ, and lipopolysaccharide. J. Cell Physiol., 151: 630-641, 1992.
53. Osanto, S , Jansen, R., and Vloemans, M. Down modulation of c-myc expression by interferon-γ and tumor necrosis factor α precedes growth arrest in human melanoma cells. Eur. J. Cancer, 28A: 1622-1627, 1992.
54. Larsson, L. G., Pettersson, M., Oberg, F., Nilsson, K., and Luscher, B. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene, 9: 1247-1252, 1994.
55. Ohtsu, H., Yamauchi, K., Yoshie, O., Tanno, Y., Saito, H., Hayashi, N., and Takishima, T. The effect of cytokines on the differentiation of an eosmophilic leukemia cell line (EoL-1) is associated with down regulation of c-myc gene expression. Cell Struct. & Funct., 18: 125-133, 1993.
56. Vairo, G., Vadiveloo, P. K., Royston, A. K., Rockman, S. P., Rock, C. O., Jackowski, S., and Hamilton, J. A. Deregulated c-myc expression overrides IFN-γ-induced macrophage growth arrest. Oncogene, 10: 1969-1976, 1995.
57. Alberts, A. S., Thorburn, A. M., Shenolikar, S., Mumby, M. C., and Feramisco, J. R. Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. Proc. Natl. Acad. Sci. USA, 90: 388-392, 1993.
58. Zhuo, S., Fan, S., Huang, S , and Kaufman, S Study of the role of retinoblastoma protein in terminal differentiation of murine erythroleukemia cells. Proc. Natl Acad. Sci. USA, 92: 4234-4238, 1995.
59. 1/S transition of hepatocyte proliferation. FEBS Lett., 352: 356-360, 1994.
60. Sardet, C., Vidal, M., Cobrinik, D., Geng, Y., Onufryk, C., Chen, A., and Weinberg, R A. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA, 92: 2403-2407, 1995.
61. Rush, E. B., Abouezzi, Z., Borgen, P I, and Anelli, A. Analysis of MTS1/CDK4 in female breast carcinomas. Cancer Lett., 89: 223-226, 1995.
62. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E , Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
63. Han, E. K., Sgambato, A., Jiang, W., Zhang, Y-J , Santella, R. M., Doki, Y., Cacace, A. M., Schieren, I., and Weinstein, I. B Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene, 10: 953-961, 1995.
64. Lew, D J., Decker, T., Strehlow, I., and Darnell, J. E., Jr. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by α- and β-interferons. Mol. Cell Biol., 11: 182-191, 1991.
65. Briken, V., Ruffner, H., Schulte, U., Schwarz, A., Reis, L F. L, Strehlow, I., Decker, T., and Staeheli, P. Interferon regulatory factor 1 is required for mouse Gbp gene action activation by γ-interferon. Mol. Cell. Biol., 15: 975-982.
66. Haradi, H., Kondo, T., Ogawa, S., Tamura, T., Kitagawa, M., Tanaka, N., Lamphier, M.S., Hirai, H., and Taniguchi, T. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia: a possible mechanism of tumor suppressor inactivation. Oncogene, 9: 3313-3320, 1994.
67. Petricoin, E., III, David, M., Fang, H., Grimley, P , Larner, A. C., and Vande Pol, S. Human cancer cell lines express a negative transcriptional regulator of the interferon regulatory factor family of DNA binding proteins. Mol. Cell Biol., 14: 1477-1486, 1994.
68. Alexandrow, M. G., and Moses, H. L. Transforming growth factor β and cell cycle regulation. Cancer Res., 55. 1452-1457, 1995.
69. 1 control in mammalian cells. J. Cell Science Suppl., 18: 69-73, 1994
70. Kouzarides, T. Transcriptional control by the retinoblastoma protein. Semin. Cancer Biol., 6: 91-98, 1995.
71. 1 arrest in senescent human fibroblasts. BioEssays, 17: 537-543, 1995.
72. Lassar, A. B., Skapek, S. X., and Novitch, B. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol., 6: 788-794, 1994.
73. Shuai, K., Stark, G. R., Kerr, I. M., and Darnell, J. E., Jr. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ Science (Washington DC), 261: 1744-1746, 1993.